TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation CAMBRIDGE, Mass. and CAMBRIDGE, United Kingdom — TriNetX, the world’s leading federated health data network, today announced that it has acquired the key assets of Zetta Genomics, a Cambridge, UK-based healthcare technology company and […]

SAN DIEGO — Biosero, Inc., developer of laboratory automation solutions that orchestrate scientific discoveries, today announced the appointment of Lucius Kemp asScientific Director, effective April 13, 2026. Kemp joins Biosero from his role as Director and Head of Automation Chemistry and Services at MilliporeSigma. He brings nearly 30 years of experience advancing laboratory automation platforms […]

HOLLYWOOD, Fla. — StarLIMS has agreed to acquire the MODA® Platform, a trusted solution for manufacturing quality assurance and control in regulated environments. The transaction is expected to close in Q2 2026, subject to customary closing conditions. StarLIMS is a leading provider of enterprise laboratory informatics software. The acquisition of the MODA® Platform from Lonza, one of […]

Veteran life sciences leader to drive enterprise growth and expand adoption of AI-ready data solutions across pharma and biotech SAN DIEGO, CA — Rancho BioSciences today announced the appointment of Chris O’Brien as Chief Executive Officer. O’Brien will lead the company’s next phase of growth as Rancho expands adoption of its AI-ready data solutions across […]

New user interface provides visual insights to guide compound optimisation  CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of the Company’s BioPharmics 3D molecular modelling platform. The new interface facilitates chemists’ access to accurate affinity predictions that guide the design of potent compounds, and reduces the synthesis and testing burden in lead optimisation. Originally developed as a command-line tool for expert computational users, QuanSA (Quantitative Surface-Field […]

New user interface provides visual insights to guide compound optimisation CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA™ plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of the Company’s BioPharmics 3D molecular modelling platform. […]

Scispot Launches MCP Server to Bring Governed AI Actions to Live Lab Workflows The new server connects Claude, ChatGPT, Cursor, and other MCP-compatible clients to experiments, samples, inventory, and approvals inside Scispot. KITCHENER, Ontario — Scispot, the AI-native lab operating system for modern life science teams, today announced the availability of the Scispot MCP Server, […]

Instem, a global leader in SaaS solutions for life sciences R&D, today announced a 5-year extension of its Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA). (Q)SAR models must be continually updated and validated to remain relevant as new compound classes and chemistries advance through pharmaceutical drug development. At the same […]

London & Minneapolis – Cenevo’s Labguru platform is delivering a comprehensive solution to centralize documentation processes at Pace® Life Sciences, a U.S.-based contract development and manufacturing organization (CDMO) and full-service good manufacturing practice (GMP) analytical laboratory service provider.   Labguru is an all-in-one cloud-based laboratory data management research-to-production platform, combining an electronic lab notebook (ELN), inventory management, registration, laboratory information management […]

BOZEMAN, Mont. — Golden Helix, a global leader in bioinformatics solutions for Next-Generation Sequencing (NGS) and precision medicine, is proud to announce a strategic agreement with the Austrian public medical genetics labs. The agreement aims to enhance the genomic capabilities of multiple laboratories within the country, supporting critical advancements in cancer and hereditary disease diagnostics. […]